To understand cytotoxic activity of Rubia cordifolia L. (Rubiaceae), which has been used as a traditional oriental medicine, the mechanism underlying cytotoxic effect of its extract on human acute Jurkat T cells was investigated. The methanol extract of roots (3 kg) of R. codifolia was evaporated, dissolved in water, and then extracted by dichloromethane. The substances in the chloroform extract showing the most cytotoxic activity were further purified by a series of preparative HPLC. The extracted active substance (65 mg) was designated as CCH1. When Jurkat T cells were treated with CCH1 at concentration ranging from 0.5 to 2.0 μg/ml, apoptotic phenomena of cells companying several subsequent biochemical reactions such as mitochondria cytochrome c release, activation of casapase-8, -9, and caspase-3, degradation of PARP and DNA fragmentation occurred via mitochondria-dependent pathway. However, abrogation of apoptosis was observed in an ectopic expression of Bcl-xL, which is a suppressor for mitochondrial cytochrome c release. These results demonstrate that the cytotoxicity of CCH1 against Jurkat T cells is attributable to apoptosis mediated by mitochodria-dependent death-signaling regulated by Bcl-xL. In addition, the CCH1 is more potent to leukemia Jurkat T cell than to human peripheral blood monocyte cells (PBMC).
Introduction
Rubia cordifolia L. (Rubiaceae) was one of the best candidates. R. cordifolia have been reported for an important oriental medicine plant which is used for anti-inflammatory [1] , immunomodulatory [6] , anticonvulsant and anxiolytic [8] and anti-tumor activity [13] . It has reported that cyclic hexapeptide isolated from R. cordifolia (Rubiaceae) shows high anti-tumor activity [4] . However, anti-tumor effect of other chemicals isolated from R. cordifolia has not been elucidated. We have found that a potential cytotoxic substance except hexapeptide also exists in roots of R. cordifolia.
The substance was partial purified, and designated as CCH1.
In this report, we investigated signaling pathways during CCH1-induced apoptosis in Jurkat T cells, with particular focus on mitochondria-dependent cell death and whether it could be protected by the ectopic expression of anti-apoptotic protein, Bcl-xL. These results showed that the CCH1-induced apoptotic cell death was mediated by mitochondrial cytochrome c release with resultant activation of caspase-8, -9 and -3, and cleavage of poly (ADP-ribose) polymerase (PARP), which was suppressed by Bcl-xL.
In the present study, we investigated approximately 80 medicine plants to find potent cytotoxicity material toward human Jurkat T cells.
Material and Methods

Isolation of a cytotoxic component from Rubia cordifolia
Rubia cordifolia Linn. (Rubiaceae) was purchased from
Hyun-dae Pharmacological Company (Busan, Korea). A sample has been deposited in the author's laboratory (Kim) .
The dried roots (3 kg) from R. cordifolia were extracted with 100% methanol. The methanol extract was evaporated (295.2 g), dissolved in water, and then extracted with dichloromethane (CH2Cl2). The CH2Cl2 fraction (82.5 g) had cytotoxicity against Jurkat T cells. The fraction was then subjected to silica gel column chromatography using a solvent system of CH2Cl2:EtOAc (50:1) to afford 60 fractions (100 ml/fraction). Analysis of each fraction was performed by a thin layer chromatography (TLC, 20 cm×20 cm, kiesel 60 F254, Merck, Germany) with a solvent system (CH2Cl2:EtOAc= 50:1), and the separated spots on the TLC were visualized with UV irradiation and 50% H2SO4. The fractions having the same pattern of separated spots on the TLC were collected together, and the cytotoxic activity of each fraction against Jurkat T cells was determined by MTT (Sigma, USA)
assay. The active fraction (4.1 g) was applied on secondary silica gel column chromatography using a solvent system (n-hexane:ethyl acetate=10:1), and subsequently on a preparative HPLC GS320 column (Japanese Engineering Instrument Co., Japan) chromatography (eluted with CH3CN: H2O=10:1, 3.0 ml/min, 245 nm). The active fraction by the HPLC GS320 column chromatography afforded 65 mg of cytotoxic compound, of which the IC50 value was 1.7 μg/ml against Jurkat T cells. The cytotoxic compound was designated as CCH1. The IC50 was expressed as concentration of sample that inhibits 50% of growth compared with a drug-free control at 37 o C for 20 hr.
Reagents, antibodies, and cells 
Cytotoxicity assay with Jurkat E6.1 T cell
Cytotoxicity of CCH1 against Jurkat T cell was determined by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay as described previously [2] .
Briefly, the cells (4×10 4 ) were added to a serial dilution of the CCH1 in 96-well plates. After incubation for 20 hr, 50 μl of the MTT solution (1.0 mg/ml) was added to each well and incubated for an additional 4 hr. After centrifugation, the supernatant was removed from each well and then 150 μl of demethyl sulfoxide (DMSO) was added to dissolve the colored formazan crystal produced from the MTT. The OD values of the solutions were measured at 540 nm using a plate reader. Viable cells were counted by a haemocytometer with trypan blue staining [7] . For the trypan blue assay, cells were cultured in a 35 mm dish and exposed to various concentration of CCH1 for 20 hr. The cells were washed with phosphate buffered saline (PBS), and trypan blue dye solution was then added to the cell suspension. After that, the viable cells were counted with a haemocytometer.
Immunoblotting
Cells pretreated with or without CCH1 were lysed with lysis buffer [137 mM NaCl, 15 mM EDTA, 1 mM sodium orthovanadate, 15 mM MgCl2, 0.1% Triton X-100, 25mM
3-N-morpholino-propanesulfonic acid (MOPS, Sigma, USA), and 2.5 μg/ml proteinase inhibitor E-64, pH 7. To detect cytochrome c, cytosolic proteins of CCH1 treated cells were extracted as described elsewhere [15] . Briefly, cells were harvested, washed with ice-cold PBS, and then incubated with 500 μl of lysis buffer (250 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM PMSF, 2.5 μg/ml proteinase inhibitor E-64, 20 mM HEPES, pH 7.2) on ice for 30 min. Cells were passed through the 26-G needle with 20 strokes. Then, the disrupted cells were centrifuged at 750 g for 10 min. The supernatant was centrifuged at 10,000 g for 25 min. After centrifugation, cytosolic fraction was frozen at -70 o C. Total lysates were used as the sample of the cytochrome c release.
Results
CCH1 has the cytotoxicity against Jurkat T cells
We tested CCH1 for cytotoxicity by using Jurkat T cells. (Fig. 1) . This means that CCH1 induces the apoptosis of Jurkat T cells.
Apoptosis is abrogated in J/Bcl-xL cells treated with CCH1.
Bcl-xL is well known to block a cell apoptosis phenomenon [10] . We tested protection of cell apoptosis in Bcl-xL over-expressed cell (J/Bcl-xL) stimulated with CCH1. Cells (4×10 4 ) treated at concentration ranging 0.5 to 2.0 μg/ml CCH1 were incubated for 20 hr and carried out with MTT assay. As shown in fig. 2 , 0.5 μg/ml treated-control cells (J/Neo) show cell viability about 90%, but cell viability was decreased dose-dependently with increased CCH1 concentration.
However, J/Bcl-xL cells show no significant cell viability changes at indicated several concentrations (Fig. 2) . These results show that over-expressed Bcl-xL proteins abrogate cytochrome c release from mitochondria and subsequent activation of apoptosis signaling. Therefore, these experiments demonstrate that CCH1 facilitates the activation of mitochondria-dependent death-signaling pathway in Jurkat T cells.
Apoptosis pathway triggered by CCH1 is through mitochondrial cytochrome c release
We investigated the apoptosis mechanism by utilizing (Fig. 3A) . Subsequently, released cytochrome c switched pro-caspase 9, downstream partner of cytochrome c related to apoptotic pathway, to active-caspase 9, dose-dependently (Fig. 3B ) in J/Neo cells. The amount of active-caspase 3 was increased in the range from 1.0 μg/ml to 2.0 μg/ml of CCH1 (Fig. 3D ) in J/Neo cells. Next, we performed Western blotting for PARP, which is the downstream target of active-caspase 3. As pro-caspase 3 ranged from 1.0 μg/ml to 2.0 μg/ml of CCH1 was activated, PARP was degraded (Fig. 3E ) in J/Neo cells. In this study, it was found that cleavages of caspase-8 and -9 in Jurkat T cells were also induced by CCH1 treatment (Fig.  3B, 3C ). Recent reports [9, 17] suggest that pro-caspase-3 can be activated through active caspase-8 in turn can cleave Bid, leading to cytochrome c release from mitochondria [12] and setting up a self-amplification loop to amplify caspase-9.
Together, these findings support the notion that apoptotic signaling of CCH1 in Jurkat T cell is regulated by mitochondrial cytochrome c release pathway.
Cytotoxic effect of CCH1 on PBMC
Cytotoxic effect of CCH1 was tested with normal PBMC ) were incubated with indicated concentrations of CCH1 for 20 hr and prepared for the cell lysates. Equivalent amounts of cell lysates were electrophoresed on 4～12% SDS gradient polyacrylamide gels and electrotransferred to Immobilon-P membrane. Western blot analysis was performed as described in materials and methods using the PIERCE Western blot detection system. Cytochrome c (A), caspase-9 (B), caspase-8 activation (C), caspase-3 activation (D), cleavage of PARP (E), and β-actin (F).
at concentration ranging from 0 to 130 μg/ml for 48 hr. As shown in fig. 4 , cell viability of Jurkat T cells was inhibited by 70% at 8.0 μg/ml of CCH1, however, PBMCs were dead by 34% at the same concentration of CCH1.
Thus, acute Jurkat T lymphoma showed sensitivity to CCH1, but normal PBMCs were resistant against CCH1. It seems that CCH1 is used as evaluation for chemotherapeutic stance, further instrument analysis is on track. Cytotoxicity of R. cordifolia against acute Jurkat T cell lymphoma was expressed as IC50 during purification, and the IC50 was determined at each step fractionated. The results showed that IC50 at methanol extract, CH2Cl2 fraction, silica gel chromatography, and preparative HPLC GS320 chromatography was 65 μg/ml, 32 μg/ml, 6.3 μg/ml, and 1.7 μg/ml, respectively. Although it has been reported that bicyclic hexapeptides (RA-IX and RA-Z) in R.cordifolia have potential anticancer activity [4] , but little is known that other biochemical including a steroid derivative in R. cordifolia shows potential cytotoxicity against cancer cells, and especially signaling pathways during apoptosis is still unknown. In this report, we have understood the cytotoxic effect, the apoptotic signaling pathway, and cell cycle distribution of CCH1
by taking advantage of antiapoptotic protein, Bcl-xL whose major function is known to suppress mitochondrial cytochrome c release [3, 14] . In Jurkat T cells exposed to CCH1, mitochondrial cytochrome c release, activation of caspase-3, -8 and -9, and cleavage of PARP were detected. These results indicated that CCH1-induced apoptotic DNA fragmentation was triggered by mitochondria-dependent death-signaling pathway including cytochrome c release and caspase activation. Recent reports [9, 16] suggest that caspase-8 activation, when triggered downstream of the mitochondrial pathway of apoptosis, may amplify caspase-9 activation through the cleavage of the pro-apoptotic protein Bid, which, in turn, elicits a further efflux of cytochrome c from mitochondria [12] . Although the current results indicate that CCH1-induced apoptosis is accompanied by mitochondrial cytochrome c release and subsequent activation of caspase cascade in Jurkat T cells, we employed two experimental approaches to confirm that these cellular events are prerequisite for the CCH1-induced apoptosis; one is for taking advantage of antiapoptotic protein Bcl-xL whose major function is known to suppress mitochondrial cytochrom c release [11, 18] and the other is to use z-VAD-fmk, a well known broad-range caspase inhibitor [17] . The CCH1-induced apoptosis was abrogated by an ectopic over-expression of Bcl-xL.
In addition, sensitivity of Jurkat T cells on CCH1 is more than that of normal PBMCs.
Collectively, these results demonstrate that CCH1, a partially purified constituent from medicinal plant R. cordifolia, induces apoptosis of Jurkat T cells via mitochondria dependent pathway by release of mitochondria cytochrome c, activation caspase-8, -9, and subsequent cascade events. These things will be helpful and useful for evaluation of its chemotherapeutic potency and tonic material.
